Zakaria AY

ORCID: 0000-0002-6966-0504 · 1 paper in corpus
2025
Pharmaceuticals (Basel, Switzerland) ·doi:10.3390/ph18050650

Background: Non-alcoholic steatohepatitis (NASH) is characterized by increased production of proinflammatory cytokines, fibrosis, and hepatocyte apoptosis. This study aimed to assess the efficacy of N-acetyl cysteine (NAC), rosuvastatin (RS…